Publikationen von Johannes Ruhnau

Ruhnau, J.; Grote, V.; Juárez-Osorio, M.; Bruder, D.; Mahour, R.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. Frontiers in Bioengineering and Biotechnology 9, 699026 (2021)

Wenzel, L.; Ruhnau, J.; Rexer, T.; Reichl, U.: Chemoenzymatic glycosylation of polypeptides using eukaryotic oligosaccharyltransferase and synthetic lipid-linked glycans. Glyco26, Taipei (Taiwan) (2023)

Ruhnau, J.: Cell-free Glycoengineering of the recombinant SARS-CoV-2 spike glycoprotein. 15th Bratislava Symposium on Saccharides (15BSS) , Smolenice (Slovakia) (2022)

Wenzel, L.; Ruhnau, J.; Hoffmann, M.; Rexer, T.; Reichl, U.: Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)

Wenzel, L.; Ruhnau, J.; Rexer, T.; Reichl, U.: Synthesis of synthetic lipid-linked oligosaccharides for the in-vitro glycoengineering of peptides. 15th Bratislava Symposium on Saccharides (15BSS), Smolenice (Slovakia) (2022)

Ruhnau, J.; Grote, V.; Juárez-Osorio, M.; Bruder, D.; Mahour, R.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. glycoNET2021, virtually (2021)